Fungicidal combinations of active substances
6 claims: 6 independent, 0 dependent
- 1Active compound combinations, comprising at least one compound of the formula and (1) a triazole derivative of the formula in which X represents chlorine or phenyl andY represents or and/or(2) the triazole derivative of the formula and/or(3) an aniline derivative of the formula in which R1 represents hydrogen or methyl, and/or(4) N-[1-(4-chloro-phenyl)-ethyl]-2,2-dichloro-1-ethyl-3-methyl-cyclopropane-carboxamide of the formula and/or(5) the zinc propylene-1,2-bis-(dithiocarbamidate) of the formula and/or(6) at least one thiocarbamate of the formula Me = Zn or Mn or a mixture of Zn and Mn and/or(7) the aniline derivative of the formula and/or(8) the compound of the formula and/or(9) the benzothiadiazole derivative of the formula and/or(10) the 8-t-butyl-2-(N-ethyl-N-n-propyl-amino)-methyl-1,4-dioxaspiro[5,4]-decane of the formula and/or(11) the compound of the formula and/or(12) the compound of the formula and/or(13) the compound of the formula and/or(14) the cyanoxime derivative of the formula and/or(15) a pyrimidine derivative of the formula in which R2 represents methyl, ―C≡C―CH3 (mepanipyrim) or cyclopropyl (cyprodinyl), and/or(16) an aniline derivative of the formula and/or(17) the morpholine derivative of the formula and/or(18) the phthalimide derivative of the formula and/or(19) the phosphorus compound of the formula and/or(20) the hydroxyethyl-triazole derivative of the formula and/or(21) the 1-[(6-chloro-3-pyridinyl)-methyl]-N-nitro-2-imidazolidinimine of the formula and/or(22) the oxazolidinedione of the formula and/or(23) the benzamide derivative of the formula and/or(24) the guanidine derivative of the formula in which m represents integers from 0 to 5 andR3 represents hydrogen (17 to 23%) or the radical of the formula and/or(25) the triazole derivative of the formula and/or(26) the halogeno-benzimidazole of the formula and/or(27) the halogenopyrimidine of the formula and/or(28) the tetrachloro-isophthalo-dinitrile of the formula and/or(29) the compound of the formula and/or(30) the pyridineamine of the formula and/or(31) the thiazolecarboxamide of the formula and/or(32) the sulphonamide of the formula and/or(33) the compound of the formula and/or(34) the compound of the formula and/or(35) the compound of the formula and/or(36) the diamide of the formula and/or(37) the methoxyacrylate derivative of the formula and/or(38) the quinoline derivative of the formula and/or(39) the phenylamide derivative of the formula and/or(40) the phenylamide derivative of the formula and/or(41) the dicarboxime derivative of the formula and/or(42) the phosphonic acid of the formula and/or(43) the pyrrole derivative of the formula and/or(44) the phenyl carbonate of the formula and/or(45) the copper compounds a) copper oxychloride (XXXXVIa) b) copper hydroxid (XXXXVIb) and/or(46) the imidazole derivative of the formula and/or(47) the triazole derivative of the formula and/or and/or and/or and/or and/or and/or and/or and/or(48) a compound of the general formula in which R1 represents unsubstituted or fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted phenyl, 2-naphthyl, 1,2,3,4-tetrahydronaphthyl or indanyl, and/or(49) N-methyl-2-(methoxyimino)-2-[2-([1-(3-tri-fluoro-methylphenyl)ethoxy]iminomethyl)-phenyl]acetamide of the formula and/or(50) 2,4-dihydro-5-methoxy-2-methyl-4-[2-([([1-(3-tri-fluoro-methylphenyl)ethylidene]amino)-oxy]methyl)phenyl]-3H-1,2,4-triazol-3-one of the formula and/or(51) the compound of the formula Combinaisons d'agents actifs, contenant au moins un composé de la formule :et (1) un dérivé triazole de la formule : dans laquelle : X représente l'atome de chlore ou le radical phényle, etY représente -C(O)- ou -CH(OH)-, et/ou(2) le dérivé triazole de la formule : et/ou(3) un dérivé aniline de la formule : dans laquelle : R1 représente l'atome d'hydrogène ou le radical méthyle, et/ou(4) le N-[1-(4-chlorophényl)éthyl]-2,2-dichloro-1-éthyl-3-méthylcyclopropanecarboxamide de la formule : et/ou(5) le zinc-propylène-1,2-bis-(dithiocarbamidate) de la formule : et/ou(6) au moins un thiocarbamate de la formule : Me = Zn ou Mn ou un mélange de Zn et de Mn, et/ou(7) le dérivé aniline de la formule : et/ou(8) le composé de la formule : et/ou(9) le dérivé benzothiazole de la formule : et/ou(10) le 8-t-butyl-2-(N-éthyl-N-n-propylamino)-méthyl-1,4-dioxaspiro[5,4]décane de la formule : (11) le composé de la formule : et/ou(12) le composé de la formule : et/ou(13) le composé de la formule : et/ou(14) le dérivé cyanoxime de la formule : et/ou(15) un dérivé pyrimidine de la formule : dans laquelle R2 représente le radical méthyle, -C≡C-CH3 (mépanipyrim) ou cyclopropyle (cyprodinyle), et/ou(16) un dérivé aniline de la formule : et/ou(17) le dérivé morpholine de la formule : et/ou(18) le dérivé phtalimide de la formule : et/ou(19) le composé du phosphore de la formule : et/ou(20) le dérivé hydroxyéthyltriazole de la formule : et/ou(21) la 1-[(6-chloro-3-pyridinyl)méthyl]-N-nitro-2-imidazolidinimine de la formule : et/ou(22) l'oxazolidinedione de la formule : et/ou(23) le dérivé benzamide de la formule : et/ou(24) le dérivé guanidine de la formule : dans laquelle m représente un nombre entier allant de 0 à 5, et R3 représente l'atome d'hydrogène (17 à 23%) ou le reste de la formule : et/ou(25) le dérivé triazole de la formule : et/ou(26) le benzimidazole halogéné de la formule : et/ou(27) l'halogénopyrimidine de la formule : et/ou(28) le tétrachloroisophtalodinitrile de la formule : et/ou(29) le composé de la formule : et/ou(30) la pyridinamine de la formule : et/ou(31) le thiazolcarboxamide de la formule : et/ou(32) le sulfonamide de la formule : et/ou(33) le composé de la formule : et/ou(34) le composé de la formule : et/ou(35) le composé de la formule : et/ou(36) le diamide de la formule : et/ou(37) le dérivé méthoxyacrylate de la formule : et/ou(38) le dérivé quinoléine de la formule : et/ou(39) le dérivé phénylamide de la formule : et/ou(40) le dérivé phénylamide de la formule : et/ou(41) le dérivé dicarboxime de la formule : et/ou(42) l'acide phosphonique de la formule : et/ou(43) le dérivé pyrrole de la formule : et/ou(44) le phénylcarbonate de la formule : et/ou(45) les composés du cuivre : (a) l'oxychlorure de cuivre (XXXXVIa) (b) l'hydroxyde de cuivre (XXXXVIb) et/ou(46) le dérivé imidazole de la formule : et/ou(47) le dérivé triazole de la formule : et/ou et/ou et/ou et/ou et/ou et/ou et/ou et/ou(48) un composé de la formule générale : dans laquelle : R1 représente un radical phényle, 2-naphtyle, 1,2,3,4-tétrahydronaphtyle ou indanyle non substitué ou substitué par l'atome de fluor, de chlore, de brome, le radical méthyle ou éthyle, et/ou(49) le N-méthyl-2-(méthoxyimino)-2-[2-([1-(3-trifluorométhylphényl)éthoxy]iminométhyl)phényl]-acétamide de la formule : et/ou(50) la 2,4-dihydro-5-méthoxy-2-méthyl-4-[2-([([1-(3-trifluorométhylphényl)éthylidène]amino)oxy]-méthyl)phényl]-3H-1,2,4-triazol-3-one de la formule : et/ou(51) le composé de la formule : Wirkstoffkombinationen, enthaltend mindestens eine Verbindung der Formel und (1) ein Triazol-Derivat der Formel in welcher X für Chlor oder Phenyl steht, undY für oder steht, und/oder(2) das Triazol-Derivat der Formel und/oder(3) ein Anilin-Derivat der Formel in welcher R1 für Wasserstoff oder Methyl steht, und/oder(4) N-[1-(4-Chlor-phenyl)-ethyl]-2,2-dichlor-1-ethyl-3-methylcyclopropan-carbonsäureamid der Formel und/oder(5) das Zink-propylen-1,2-bis-(dithiocarbamidat) der Formel und/oder(6) mindestens ein Thiocarbamat der Formel Me = Zn oder Mn oder Gemisch aus Zn und Mn und/oder(7) das Anilin-Derivat der Formel und/oder(8) die Verbindung der Formel und/oder(9) das Benzothiadiazol-Derivat der Formel und/oder(10) das 8-t-Butyl-2-(N-ethyl-N-n-propyl-amino)-methyl-1,4-dioxaspiro[5,4]-decan der Formel und/oder(11) die Verbindung der Formel und/oder(12) die Verbindung der Formel und/oder(13) die Verbindung der Formel und/oder(14) das Cyanoxim-Derivat der Formel und/oder(15) ein Pyrimidin-Derivat der Formel in welcher R2 für Methyl, ―C≡C―CH3 (Mepanipyrim) oder Cyclopropyl (Cyprodinyl) steht, und/oder(16) ein Anilin-Derivat der Formel und/oder(17) das Morpholin-Derivat der Formel und/oder(18) das Phthalimid-Derivat der Formel und/oder(19) die Phosphor-Verbindung der Formel und/oder(20) das Hydroxyethyl-triazol-Derivat der Formel und/oder(21) das 1-[(6-Chlor-3-pyridinyl)-methyl]-N-nitro-2-imidazolidinimin der Formel und/oder(22) das Oxazolidindion der Formel und/oder(23) das Benzamid-Derivat der Formel und/oder(24) das Guanidin-Derivat der Formel in welcher m für ganze Zahlen von 0 bis 5 steht undR3 für Wasserstoff (17 bis 23 %) oder den Rest der Formel steht, und/oder(25) das Triazol-Derivat der Formel und/oder(26) das Halogen-benzimidazol der Formel und/oder(27) das Halogenpyrimidin der Formel und/oder(28) das Tetrachlor-isophthalo-dinitril der Formel und/oder(29) die Verbindung der Formel und/oder(30) das Pyridinamin der Formel und/oder(31) das Thiazolcarboxamid der Formel und/oder(32) das Sulfonamid der Formel und/oder(33) der Verbindung der Formel und/oder(34) die Verbindung der Formel und/oder(35) die Verbindung der Formel und/oder(36) dem Diamid der Formel und/oder(37) das Methoxyacrylat-Derivat der Formel und/oder(38) das Chinolin-Derivat der Formel und/oder(39) das Phenylamid-Derivat der Formel und/oder(40) das Phenylamid-Derivat der Formel und/oder(41) das Dicarboxim-Derivat der Formel und/oder(42) die Phosphonsäure der Formel und/oder(43) das Pyrrol-Derivat der Formel und/oder(44) das Phenylcarbonat der Formel und/oder(45) die Kupferverbindungen a) Kupferoxychlorid (XXXXVIa) b) Kupferhydroxid (XXXXVIb) und/oder(46) das Imidazol-Derivat der Formel und/oder(47) das Triazolderivat der Formel und/oder und/oder und/oder und/oder und/oder und/oder und/oder und/oder(48) eine Verbindung der allgemeinen Formel in welcher R1 für unsubstituiertes oder durch Fluor, Chlor, Brom, Methyl oder Ethyl substituiertes Phenyl, 2-Naphthyl, 1,2,3,4-Tetrahydronaphthyl oder Indanyl steht, und/oder(49) N-Methyl-2-(methoxyimino)-2-[2-([1-(3-tri-fluoro-methylphenyl)ethoxy]iminomethyl)phenyl]acetamid der Formel und/oder(50) 2,4-Dihydro-5-methoxy-2-methyl-4-[2-([([ 1-(3-tri-fluoromethylphenyl)ethylidene]amino)oxy]methyl)phenyl]-3H-1,2,4-triazol-3-one der Formel und/oder(51) die Verbindung der Formel
- 2Active compound combinations according to Claim 1, comprising at least one compound of the formula (I) as defined in Claim 1 and (3) an aniline derivative of the formula and/or(5) the zinc propylene-1,2-bis-(dithiocarbamidate) of the formula and/or(6) at least one thiocarbamate of the formula Me = mixture of Zn and Mn and/or(7) the aniline derivative of the formula and/or(8) the compound of the formula and/or(11) the compound of the formula and/or(12) the compound of the formula and/or(13) the compound of the formula and/or(18) the phthalimide derivative of the formula and/or(20) the hydroxyethyl-triazole derivative of the formula and/or(26) the halogeno-benzimidazole of the formula and/or(27) the halogenopyrimidine of the formula and/or(28) the tetrachloro-isophthalo-dinitrile of the formula and/or(30) the pyridinamine of the formula and/or(45) the copper compounds a) copper oxychloride (XXXXVIa) b) copper hydroxide (XXXXVIb). Combinaisons d'agents actifs suivant la revendication 1, contenant au moins un composé de la formule (I) comme défini à la revendication 1, et (3) un dérivé aniline de la formule :et/ou(5) le zinc-propylène-1,2-bis-(dithiocarbamidate) de la formule : et/ou(6) au moins un thiocarbamate de la formule : Me = mélange de Zn et de Mn, et/ou(7) le dérivé aniline de la formule : et/ou(8) le composé de la formule : et/ou(11) le composé de la formule : et/ou(12) le composé de la formule : et/ou(13) le composé de la formule : et/ou(18) le dérivé phtalimide de la formule : et/ou(20) le dérivé hydroxyéthyltriazole de la formule : et/ou(26) le benzimidazole halogéné de la formule : et/ou(27) l'halogénopyrimidine de la formule : et/ou(28) le tétrachloroisophtalodinitrile de la formule : et/ou(30) la pyridinamine de la formule : et/ou(45) les composés du cuivre : (a) l'oxychlorure de cuivre (XXXXVIa)(b) l'hydroxyde de cuivre (XXXXVIb) Wirkstoffkombinationen, gemäß Anspruch 1, enthaltend mindestens eine Verbindung der Formel (I) wie in Anspruch 1 definiert und (3) ein Anilin-Derivat der Formel und/oder(5) das Zink-propylen-1,2-bis-(dithiocarbamidat) der Formel und/oder(6) mindestens ein Thiocarbamat der Formel Me = Gemisch aus Zn und Mn und/oder(7) das Anilin-Derivat der Formel und/oder(8) die Verbindung der Formel und/oder(11) die Verbindung der Formel und/oder(12) die Verbindung der Formel und/oder(13) die Verbindung der Formel und/oder(18) das Phthalimid-Derivat der Formel und/oder(20) das Hydroxyethyl-triazol-Derivat der Formel und/oder(26) das Halogen-benzimidazol der Formel und/oder(27) das Halogenpyrimidin der Formel und/oder(28) das Tetrachlor-isophthalo-dinitril der Formel und/oder(30) das Pyridinamin der Formel und/oder(45) die Kupferverbindungen a) Kupferoxychlorid (XXXXVIa) b) Kupferhydroxid (XXXXVIb).
- 3Agent suivant la revendication 1, caractérisé en ce que dans les combinaisons d'agents actifs, le rapport pondéral de l'agent actif de la formule (I) à l'agent actif du groupe (1), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (2), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (3), se situe dans l'intervalle allant de 1:1 à 1:50 ;l'agent actif du groupe (4), se situe dans l'intervalle allant de 1:0,1 à 1:10 ;l'agent actif du groupe (5), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (6), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (7), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (8), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (9), se situe dans l'intervalle allant de 1:0,02 à 1:50 ;l'agent actif du groupe (10), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (11), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (12), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (13), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (14), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (15), se situe dans l'intervalle allant de 1:0,2 à 1:50 ;l'agent actif du groupe (16), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (17), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (18), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (19), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (20), se situe dans l'intervalle allant de 1:0,02 à 1:50 ;l'agent actif du groupe (21), se situe dans l'intervalle allant de 1:0,05 à 1:20 ;l'agent actif du groupe (22), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (23), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (24), se situe dans l'intervalle allant de 1:0,1 à 1:150 ;l'agent actif du groupe (25), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (26), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (27), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (28), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (29), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (30), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (31), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (32), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (33), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (34), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (35), se situe dans l'intervalle allant de 1:1 à 1:50 ;l'agent actif du groupe (36), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (37), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (38), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (39), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (40), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (41), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (42), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (43), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (44), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (45a), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (45b), se situe dans l'intervalle allant de 1:1 à 1:150 ;l'agent actif du groupe (46), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47a), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47b), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47c), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47d), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47e), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47f), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47g), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (47h), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (48), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (49), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (50), se situe dans l'intervalle allant de 1:0,1 à 1:50 ;l'agent actif du groupe (51), se situe dans l'intervalle allant de 1:0,1 à 1:50. Composition according to Claim 1, characterized in that in the active compound combinations the weight ratio of active compound of the formula (I) to - active compound of group (1) is from 1:0.1 to 1:50,- active compound of group (2) is from 1:0.1 to 1:50,- active compound of group (3) is from 1:1 to 1:150,- active compound of group (4) is from 1:0.1 to 1:10,- active compound of group (5) is from 1:1 to 1:150,- active compound of group (6) is from 1:1 to 1:150,- active compound of group (7) is from 1:0.1 to 1:50,- active compound of group (8) is from 1:0.1 to 1:50,- active compound of group (9) is from 1:0.02 to 1:50,- active compound of group (10) is from 1:0.1 to 1:50,- active compound of group (11) is from 1:0.1 to 1:50,- active compound of group (12) is from 1:0.1 to 1:50,- active compound of group (13) is from 1:0.1 to 1:50,- active compound of group (14) is from 1:0.1 to 1:50,- active compound of group (15) is from 1:0.2 to 1:50,- active compound of group (16) is from 1:0.1 to 1:50,- active compound of group (17) is from 1:0.1 to 1:50,- active compound of group (18) is from 1:1 to 1:150,- active compound of group (19) is from 1:0.1 to 1:150,- active compound of group (20) is from 1:0.02 to 1:50,- active compound of group (21) is from 1:0.05 to 1:20,- active compound of group (22) is from 1:0.1 to 1:50,- active compound of group (23) is from 1:0.1 to 1:50,- active compound of group (24) is from 1:0.1 to 1:150,- active compound of group (25) is from 1:0.1 to 1:50,- active compound of group (26) is from 1:0.1 to 1:50,- active compound of group (27) is from 1:0.1 to 1:50,- active compound of group (28) is from 1:1 to 1:150,- active compound of group (29) is from 1:1 to 1:150,- active compound of group (30) is from 1:0.1 to 1:50,- active compound of group (31) is from 1:0.1 to 1:50,- active compound of group (32) is from 1:0.1 to 1:50,- active compound of group (33) is from 1:0.1 to 1:50,- active compound of group (34) is from 1:0.1 to 1:50,- active compound of group (35) is from 1:1 to 1:50,- active compound of group (36) is from 1:1 to 1:150,- active compound of group (37) is from 1:0.1 to 1:50,- active compound of group (38) is from 1:0.1 to 1:50,- active compound of group (39) is from 1:0.1 to 1:50,- active compound of group (40) is from 1:0.1 to 1:50,- active compound of group (41) is from 1:1 to 1:150,- active compound of group (42) is from 1:1 to 1:150,- active compound of group (43) is from 1:0.1 to 1:50,- active compound of group (44) is from 1:0.1 to 1:50,- active compound of group (45a) is from 1:1 to 1:150,- active compound of group (45b) is from 1:1 to 1:150,- active compound of group (46) is from 1:0.1 to 1:50,- active compound of group (47a) is from 1:0.1 to 1:50,- active compound of group (47b) is from 1:0,1 to 1:50,- active compound of group (47c) is from 1:0.1 to 1:50,- active compound of group (47d) is from 1:0.1 to 1:50,- active compound of group (47e) is from 1:0.1 to 1:50,- active compound of group (47f) is from 1:0.1 to 1:50,- active compound of group (47g) is from 1:0.1 to 1:50,- active compound of group (47h) is from 1:0.1 to 1:50,- active compound of group (48) is from 1:0.1 to 1:50,- active compound of group (49) is from 1:0.1 to 1:50,- active compound of group (50) is from 1:0.1 to 1:50,- active compound of group (51) is from 1:0.1 to 1:50. Mittel gemäß Anspruch 1, dadurch gekennzeichnet, dass in den Wirkstoffkombinationen das Gewichtsverhältnis von Wirkstoff der Formel (I) zu - Wirkstoff der Gruppe (1) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (2) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (3) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (4) zwischen 1:0,1 und 1:10 liegt,- Wirkstoff der Gruppe (5) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (6) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (7) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (8) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (9) zwischen 1:0,02 und 1:50 liegt,- Wirkstoff der Gruppe (10) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (11) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (12) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (13) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (14) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (15) zwischen 1:0,2 und 1:50 liegt,- Wirkstoff der Gruppe (16) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (17) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (18) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (19) zwischen 1:0,1 und 1:150 liegt,- Wirkstoff der Gruppe (20) zwischen 1:0,02 und 1:50 liegt,- Wirkstoff der Gruppe (21) zwischen 1:0,05 und 1:20 liegt,- Wirkstoff der Gruppe (22) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (23) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (24) zwischen 1:0,1 und 1:150 liegt,- Wirkstoff der Gruppe (25) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (26) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (27) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (28) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (29) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (30) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (31) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (32) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (33) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (34) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (35) zwischen 1:1 und 1:50 liegt,- Wirkstoff der Gruppe (36) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (37) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (38) zwischenl :0,1 und 1:50 liegt,- Wirkstoff der Gruppe (39) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (40) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (41) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (42) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (43) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (44) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (45a) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (45b) zwischen 1:1 und 1:150 liegt,- Wirkstoff der Gruppe (46) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47a) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47b) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47c) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47d) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47e) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47f) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47g) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (47h) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (48) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (49) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (50) zwischen 1:0,1 und 1:50 liegt,- Wirkstoff der Gruppe (51) zwischen 1:0,1 und 1:50 liegt.
- 4Method for controlling fungi, characterized in that active compound combinations according to at least one of Claims 1 to 3 are applied to the fungi and/or their habitat. Procédé pour lutter contre les champignons, caractérisé en ce que l'on applique des combinaisons d'agents actifs suivant au moins l'une des revendications 1 à 3 sur les champignons et/ou leur biotope. Verfahren zur Bekämpfung von Pilzen, dadurch gekennzeichnet, daß man Wirkstoffkombinationen gemäß mindestens einem der Ansprüche 1 bis 3 auf die Pilze und/oder deren Lebensraum ausbringt.
- 5Use of active compound combinations according to any of Claims 1 to 3 for controlling fungi. Utilisation des combinaisons d'agents actifs suivant au moins l'une des revendications 1 à 3, pour lutter contre les champignons. Verwendung von Wirkstoffkombinationen gemäß mindestens einem der Ansprüche 1 bis 3 zur Bekämpfung von Pilzen.
- 6Process for preparing fungicidal compositions, characterized in that active compound combinations according to any of Claims 1 to 3 are mixed with extenders and/or surfactants. Procédé de préparation d'agents fongicides, caractérisé en ce que l'on mélange des combinaisons d'agents actifs suivant au moins l'une des revendications 1 à 3 avec des diluants et/ou tensioactifs. Verfahren zur Herstellung von fungiziden Mitteln, dadurch gekennzeichnet, daß man Wirkstoffkombinationen gemäß mindestens einem der Ansprüche 1 bis 3 mit Streckmitteln und/oder oberflächenaktiven Stoffen vermischt.
Independent claims6
60 paragraphs, as filed
The present invention relates to new combinations of active ingredients which consist of a known fluorobenzothiazole derivative on the one hand and other known active ingredients on the other hand and are very well suited for combating phytopathogenic fungi.
It is already known that isopropyl 1 - ({[1- (6-fluoro-1,3-benzothiazol-2-yl) ethyl] amino} carbonyl) -2-methylpropylcarbamate has fungicidal properties (cf. EP-A1- 775 696). The effectiveness of this substance is good, but leaves something to be desired at low application rates in some cases.
Furthermore, it is already known that numerous triazole derivatives, aniline derivatives, dicarboximides and other heterocycles can be used to combat fungi (cf. EP-A 0 040 345, DE-A 22 01 063, DE-A 23 24 010, Pesticide Manual, 9th Edition (1991), pages 249 and 827, EP-A 0 382 375 and EP-A 0 515 901). However, the effect of these substances is not always sufficient at low application rates.
Finally, it is also known that 1 - [(6-chloro-3-pyridinyl) methyl] -N-nitro-2-imidazolidinimine can be used to control animal pests, such as insects (cf. Pesticide Manual, 9th Edition (1991 ), Page 491). Fungicidal properties of this substance have not yet been described.
Furthermore, it is already known that 1- (3,5-dimethyl-isoxazole-4-sulfonyl) -2-chloro-6,6-difluoro- [1,3] dioxolo- [4,5f] -benzimidazole has fungicidal properties (see WO 97-06171).
Furthermore, it is already known that substituted azadioxacycloalkenes have a fungicidal action (cf. EP-B-712 396).
Finally, it is also known that substituted halopyrimidines have fungicidal properties (cf. DE-A1-196 46 407, EP-B-712 396).
It has now been found that the new drug combinations of a fluorobenzothiazole derivative of the formula<chemistry id="chem0001" num="0001"><img file="EP1239733B1_D0001.tif" /></chemistry> and<ul id="ul0001" list-style="none"><li>(1) a triazole derivative of the formula<chemistry id="chem0002" num="0002"><img file="EP1239733B1_D0002.tif" /></chemistry> in which<dl id="dl0001"><dt>X</dt><dd>represents chlorine or phenyl, and</dd><dt>Y</dt><dd>For<chemistry id="chem0003" num="0003"><img file="EP1239733B1_D0003.tif" /></chemistry> or<chemistry id="chem0004" num="0004"><img file="EP1239733B1_D0004.tif" /></chemistry> stands,</dd></dl> and or</li><li>(2) the triazole derivative of the formula<chemistry id="chem0005" num="0005"><img file="EP1239733B1_D0005.tif" /></chemistry> and or</li><li>(3) an aniline derivative of the formula<chemistry id="chem0006" num="0006"><img file="EP1239733B1_D0006.tif" /></chemistry> in which<dl id="dl0002"><dt>R<sup>1</sup></dt><dd>represents hydrogen or methyl,</dd></dl> and or</li><li>(4) N- [1- (4-chlorophenyl) ethyl] -2,2-dichloro-1-ethyl-3-methylcyclopropane carboxamide of the formula<chemistry id="chem0007" num="0007"><img file="EP1239733B1_D0007.tif" /></chemistry> and or</li><li>(5) the zinc propylene 1,2-bis (dithiocarbamidate) of the formula<chemistry id="chem0008" num="0008"><img file="EP1239733B1_D0008.tif" /></chemistry> and or</li><li>(6) at least one thiocarbamate of the formula<chemistry id="chem0009" num="0009"><img file="EP1239733B1_D0009.tif" /></chemistry> Me = Zn or Mn or mixture of Zn and Mn and or</li><li>(7) the aniline derivative of the formula<chemistry id="chem0010" num="0010"><img file="EP1239733B1_D0010.tif" /></chemistry> and or</li><li>(8) the compound of formula<chemistry id="chem0011" num="0011"><img file="EP1239733B1_D0011.tif" /></chemistry> and or</li><li>(9) the benzothiadiazole derivative of the formula<chemistry id="chem0012" num="0012"><img file="EP1239733B1_D0012.tif" /></chemistry> and or</li><li>(10) the 8-t-butyl-2- (N-ethyl-Nn-propylamino) methyl-1,4-dioxaspiro [5,4] decane of the formula<chemistry id="chem0013" num="0013"><img file="EP1239733B1_D0013.tif" /></chemistry> and or</li><li>(11) the compound of formula<chemistry id="chem0014" num="0014"><img file="EP1239733B1_D0014.tif" /></chemistry> and or</li><li>(12) the compound of formula<chemistry id="chem0015" num="0015"><img file="EP1239733B1_D0015.tif" /></chemistry> and or</li><li>(13) the compound of the formula<chemistry id="chem0016" num="0016"><img file="EP1239733B1_D0016.tif" /></chemistry> and or</li><li>(14) the cyanoxime derivative of the formula<chemistry id="chem0017" num="0017"><img file="EP1239733B1_D0017.tif" /></chemistry> and or</li><li>(15) a pyrimidine derivative of the formula<chemistry id="chem0018" num="0018"><img file="EP1239733B1_D0018.tif" /></chemistry> in which<dl id="dl0003"><dt>R<sup>2</sup></dt><dd>for methyl, ―C≡C ― CH<sub>3</sub> (Mepanipyrim) or cyclopropyl (cyprodinyl),</dd></dl> and or</li><li>(16) an aniline derivative of the formula<chemistry id="chem0019" num="0019"><img file="EP1239733B1_D0019.tif" /></chemistry> and or</li><li>(17) the morpholine derivative of the formula<img file="EP1239733B1_D0020.tif" /> and or</li><li>(18) the phthalimide derivative of the formula<chemistry id="chem0020" num="0020"><img file="EP1239733B1_D0021.tif" /></chemistry> and or</li><li>(19) the phosphorus compound of the formula<chemistry id="chem0021" num="0021"><img file="EP1239733B1_D0022.tif" /></chemistry> and or</li><li>(20) the hydroxyethyl triazole derivative of the formula<chemistry id="chem0022" num="0022"><img file="EP1239733B1_D0023.tif" /></chemistry> and or</li><li>(21) the 1 - [(6-chloro-3-pyridinyl) methyl] -N-nitro-2-imidazolidinimine of the formula<chemistry id="chem0023" num="0023"><img file="EP1239733B1_D0024.tif" /></chemistry> and or</li><li>(22) the oxazolidinedione of the formula<chemistry id="chem0024" num="0024"><img file="EP1239733B1_D0025.tif" /></chemistry> and or</li><li>(23) the benzamide derivative of the formula<chemistry id="chem0025" num="0025"><img file="EP1239733B1_D0026.tif" /></chemistry> and or</li><li>(24) a guanidine derivative of the formula<chemistry id="chem0026" num="0026"><img file="EP1239733B1_D0027.tif" /></chemistry> in which<dl id="dl0004"><dt>m</dt><dd>stands for integers from 0 to 5 and</dd><dt>R<sup>3</sup></dt><dd>for hydrogen (17 to 23%) or the rest of the formula</dd></dl><chemistry id="chem0027" num="0027"><img file="EP1239733B1_D0028.tif" /></chemistry> stands, and or</li><li>(25) the triazole derivative of the formula<chemistry id="chem0028" num="0028"><img file="EP1239733B1_D0029.tif" /></chemistry> and or</li><li>(26) the halogenobenzimidazole of the formula<chemistry id="chem0029" num="0029"><img file="EP1239733B1_D0030.tif" /></chemistry> and or</li><li>(27) the halopyrimidine of the formula<chemistry id="chem0030" num="0030"><img file="EP1239733B1_D0031.tif" /></chemistry> and or</li><li>(28) the tetrachloroisophthalodinitrile of the formula<chemistry id="chem0031" num="0031"><img file="EP1239733B1_D0032.tif" /></chemistry> and or</li><li>(29) the compound of formula<chemistry id="chem0032" num="0032"><img file="EP1239733B1_D0033.tif" /></chemistry> and or</li><li>(30) the pyridinamine of the formula<chemistry id="chem0033" num="0033"><img file="EP1239733B1_D0034.tif" /></chemistry> and or</li><li>(31) the thiazole carboxamide of the formula<chemistry id="chem0034" num="0034"><img file="EP1239733B1_D0035.tif" /></chemistry> and or</li><li>(32) the sulfonamide of the formula<chemistry id="chem0035" num="0035"><img file="EP1239733B1_D0036.tif" /></chemistry> and or</li><li>(33) the compound of formula<chemistry id="chem0036" num="0036"><img file="EP1239733B1_D0037.tif" /></chemistry> and or</li><li>(34) the compound of formula<chemistry id="chem0037" num="0037"><img file="EP1239733B1_D0038.tif" /></chemistry> and or</li><li>(35) the compound of formula<chemistry id="chem0038" num="0038"><img file="EP1239733B1_D0039.tif" /></chemistry> and or</li><li>(36) the diamide of the formula<chemistry id="chem0039" num="0039"><img file="EP1239733B1_D0040.tif" /></chemistry> and or</li><li>(37) the methoxyacrylate derivative of the formula<chemistry id="chem0040" num="0040"><img file="EP1239733B1_D0041.tif" /></chemistry> and or</li><li>(38) the quinoline derivative of the formula<chemistry id="chem0041" num="0041"><img file="EP1239733B1_D0042.tif" /></chemistry> and or</li><li>(39) the phenylamide derivative of the formula<chemistry id="chem0042" num="0042"><img file="EP1239733B1_D0043.tif" /></chemistry> and or</li><li>(40) the phenylamide derivative of the formula<chemistry id="chem0043" num="0043"><img file="EP1239733B1_D0044.tif" /></chemistry> and or</li><li>(41) the dicarboxime derivative of the formula<chemistry id="chem0044" num="0044"><img file="EP1239733B1_D0045.tif" /></chemistry> and or</li><li>(42) the phosphonic acid of the formula<chemistry id="chem0045" num="0045"><img file="EP1239733B1_D0046.tif" /></chemistry> and or</li><li>(43) the pyrrole derivative of the formula<chemistry id="chem0046" num="0046"><img file="EP1239733B1_D0047.tif" /></chemistry> and or</li><li>(44) the phenyl carbonate of the formula<chemistry id="chem0047" num="0047"><img file="EP1239733B1_D0048.tif" /></chemistry> and or</li><li>(45) the copper compounds<ul id="ul0002" list-style="none" compact="compact"><li>a) Copper oxychloride (XXXXVIa) </li><li>b) Copper hydroxide (XXXXVIb)</li></ul> and or</li><li>(46) the imidazole derivative of the formula<chemistry id="chem0048" num="0048"><img file="EP1239733B1_D0049.tif" /></chemistry> and or</li><li>(47) a triazole derivative of the formula<chemistry id="chem0049" num="0049"><img file="EP1239733B1_D0050.tif" /></chemistry> and or<chemistry id="chem0050" num="0050"><img file="EP1239733B1_D0051.tif" /></chemistry> and or<chemistry id="chem0051" num="0051"><img file="EP1239733B1_D0052.tif" /></chemistry> and or<chemistry id="chem0052" num="0052"><img file="EP1239733B1_D0053.tif" /></chemistry> and or<chemistry id="chem0053" num="0053"><img file="EP1239733B1_D0054.tif" /></chemistry> and or<chemistry id="chem0054" num="0054"><img file="EP1239733B1_D0055.tif" /></chemistry> and or<chemistry id="chem0055" num="0055"><img file="EP1239733B1_D0056.tif" /></chemistry> and or<chemistry id="chem0056" num="0056"><img file="EP1239733B1_D0057.tif" /></chemistry> and or</li><li>(48) a compound of the general formula<chemistry id="chem0057" num="0057"><img file="EP1239733B1_D0058.tif" /></chemistry> in which<dl id="dl0005"><dt>R<sup>1</sup></dt><dd>represents phenyl, 2-naphthyl, 1,2,3,4-tetrahydronaphthyl or indanyl which is unsubstituted or substituted by fluorine, chlorine, bromine, methyl or ethyl,</dd></dl> and or</li><li>(49) N-Methyl-2- (methoxyimino) -2- [2 - ([1- (3-tri-fluoro-methylphenyl) ethoxy] iminomethyl) phenyl] acetamide of the formula<chemistry id="chem0058" num="0058"><img file="EP1239733B1_D0059.tif" /></chemistry> and or</li><li>(50) 2,4-dihydro-5-methoxy-2-methyl-4- [2 - ([([1- (3-tri-fluoromethylphenyl) ethylidene] amino) oxy] methyl) phenyl] -3H-1, 2,4-triazol-3-one of the formula<chemistry id="chem0059" num="0059"><img file="EP1239733B1_D0060.tif" /></chemistry> and or</li><li>(51) the compound of formula<chemistry id="chem0060" num="0060"><img file="EP1239733B1_D0061.tif" /></chemistry></li></ul> have very good fungicidal properties.
Surprisingly, the fungicidal action of the active compound combinations according to the invention is considerably higher than the sum of the actions of the individual active compounds. So there is an unforeseeable, real synergistic effect and not just an addition.
It can be seen from the structural formula for the active ingredient of the formula (I) that the compound has two asymmetrically substituted carbon atoms. The product can therefore be present as a mixture of different isomers or in the form of a single isomer.
Preferred compounds of the formula (I) are compounds in which the amino acid part is formed from i-propyloxycarbonyl-L-valine and the fluorobenzothiazolethylamine part is racemic, but in particular has the (R) configuration.
Formula (II) includes the compounds
1- (4-chlorophenoxy) -3,3-dimethyl-1- (1,2,4-triazol-1-yl) butan-2-one of the formula<chemistry id="chem0061" num="0061"><img file="EP1239733B1_D0062.tif" /></chemistry>
1- (4-chlorophenoxy) -3,3-dimethyl-1- (1,2,4-triazol-1-yl) butan-2-ol of the formula<chemistry id="chem0062" num="0062"><img file="EP1239733B1_D0063.tif" /></chemistry> and
1- (4-phenylphenoxy) -3,3-dimethyl-1- (1,2,4-triazol-1-yl) butan-2-ol of the formula<chemistry id="chem0063" num="0063"><img file="EP1239733B1_D0064.tif" /></chemistry>
Formula (IV) comprises the aniline derivatives of the formulas
<chemistry id="chem0064" num="0064"><img file="EP1239733B1_D0065.tif" /></chemistry> and<chemistry id="chem0065" num="0065"><img file="EP1239733B1_D0066.tif" /></chemistry>
It can be seen from the structural formula for the active ingredient of the formula (V) that the compound has three asymmetrically substituted carbon atoms. The product can therefore be present as a mixture of different isomers or in the form of a single component. The compounds N- (R) - [1- (4-chlorophenyl) ethyl] - (1S) -2,2-dichloro-1-ethyl-3t-methyl-1R-cyclopropanecarboxamide of the formula are particularly preferred<chemistry id="chem0066" num="0066"><img file="EP1239733B1_D0067.tif" /></chemistry> and N- (R) - [1- (4-chlorophenyl) ethyl] - (1R) -2,2-dichloro-1-ethyl-3t-methyl-1R-cyclopropanecarboxamide of the formula<img file="EP1239733B1_D0068.tif" />
Formula (VII) includes the compounds
(VIIa) Me = Zn (Zineb), (VIIb) Me = Mn (Maneb) and (VIIc) mixture of (VIIa) and (VIIb) (Mancozeb).
Formula (XVI) includes the compounds
(XVIa) R<sup>2</sup> = CH<sub>3</sub> (Pyrimethanil) and<chemistry id="chem0067" num="0067"><img file="EP1239733B1_D0069.tif" /></chemistry> (XVIc) R<sup>2</sup>= -C≡C-CH<sub>3</sub> (Mepanipyrim)
The compound of formula (XVII) can be methyl N- (2,6-dimethylphenyl) -N- (methoxyacetyl) -DL-alaninate (metalaxyl, XVIIa) or methyl N- (2,6-dimethylphenyl) -N- ( methoxyacetyl) -D-alaninate (Metalaxyl-M, XVIIb) are present.
The hydroxyethyl-triazole derivative of the formula (XXI) can be in the "thiono" form of the formula<chemistry id="chem0068" num="0068"><img file="EP1239733B1_D0070.tif" /></chemistry> or in the tautomeric "mercapto" form of the formula<chemistry id="chem0069" num="0069"><img file="EP1239733B1_D0071.tif" /></chemistry> are available. For the sake of simplicity, only the "Thiono" form is listed.
The guanidine derivative of the formula (XXV) is a mixture of substances with the common name guazatine.
It can be seen from the structural formula for the active compounds of the formula (XXXXIX) that the compounds can be present as E or Z isomers. The product can therefore be present as a mixture of different isomers or in the form of a single isomer. Compounds of the formula (XXXXIX) in which the compounds of the formula (XXXXIX) are present as E isomers are preferred. The compounds of the formulas are particularly preferred<chemistry id="chem0070" num="0070"><img file="EP1239733B1_D0072.tif" /></chemistry> and<chemistry id="chem0071" num="0071"><img file="EP1239733B1_D0073.tif" /></chemistry> and<chemistry id="chem0072" num="0072"><img file="EP1239733B1_D0074.tif" /></chemistry> and<chemistry id="chem0073" num="0073"><img file="EP1239733B1_D0075.tif" /></chemistry> and<chemistry id="chem0074" num="0074"><img file="EP1239733B1_D0076.tif" /></chemistry> and<chemistry id="chem0075" num="0075"><img file="EP1239733B1_D0077.tif" /></chemistry> and their isomers.
The following active ingredients are particularly preferred as mixing partners of the compounds of the formula (I):<ul id="ul0003" list-style="none" compact="compact"><li>(3) tolylfluanide (IVb),</li><li>(5) Propineb (VI),</li><li>(6) Mancozeb (VIIc),</li><li>(7) fenhexamide (VIII),</li><li>(8) iprovalicarb (VIII),</li><li>(11) azoxystrobin (XII),</li><li>(12) trifloxystrobin (XIII),</li><li>(13) compound of the formula (XIV),</li><li>(18) Folpet (XIX),</li><li>(20) compound of the formula (XXI),</li><li>(26) compound of the formula (XXVII),</li><li>(27) compound of the formula (XXVIII),</li><li>(28) chlorothalonil (XXIX),</li><li>(30) fluazinam (XXXI), and</li><li>(45) Copper compounds<ul id="ul0004" list-style="none" compact="compact"><li>a) Copper oxychloride (XXXXVIa)</li><li>b) Copper hydroxide (XXXXVIb).</li></ul></li></ul>
The components present in the active compound combinations according to the invention in addition to a halogenobenzimidazole of the formula (XXVII) are also known.
The active substances are described in detail in the following publications:<ul id="ul0005" list-style="none"><li>(1) compounds of the formula (II) DE-A 22 01 063 DE-A 23 24 010</li><li>(2) compound of formula (III) EP-A 0 040 345</li><li>(3) compounds of the formula (IV) Pesticide Manual, 9th. Ed. (1991), pages 249 and 827</li><li>(4) Compound of formula (V) and its individual derivatives EP-A 0 341 475</li><li>(5) Compound of Formula (VI) Pesticide Manual, 9th. Ed. (1991), page 726</li><li>(6) compounds of the formula (VII) Pesticide Manual, 9th. Ed. (1991), pages 529, 531 and 866</li><li>(7) compound of formula (VIII) EP-A 0 339 418</li><li>(8) Compound of Formula (IX) EP-A 0 472 996</li><li>(9) compound of formula (X) EP-A 0 313 512</li><li>(10) compound of formula (XI) EP-A 0 281 842</li><li>(11) compound of formula (XII) EP-A 0 382 375</li><li>(12) compound of formula (XIII) EP-A-460 575</li><li>(13) compound of formula (XIV) DE-A 196 02 095</li><li>(14) compound of formula (XV) Pesticide Manual, 9th. Ed. (1991), page 206</li><li>(15) compounds of the formula (XVI) EP-A 0 270 111 EP-A 0 310 550</li><li>(16) compound of formula (XVII) Pesticide Manual, 9th. Ed. (1991), page 554</li><li>(17) Compound of Formula (XVIII) EP-A 0 219 756</li><li>(18) compound of the formula (XIX) Pesticide Manual, 9th. Ed. (1991), page 431</li><li>(19) compound of the formula (XX) Pesticide Manual, 9th. Ed. (1991), page 443</li><li>(20) compound of the formula (XXI) WO 96-16048</li><li>(21) Compound of Formula (XXII) Pesticide Manual, 9th. Ed. (1991), page 491</li><li>(22) Compound of Formula (XXIII) EP-A 0 393 911</li><li>(23) compound of the formula (XXIV) EP-A 0 600 629</li><li>(24) Substance of the formula (XXV) Pesticide Manual, 9th. Ed. (1991), page 461</li><li>(25) compound of the formula (XXVI) Pesticide Manual, 9th. Ed. (1991), page 654</li><li>(26) compound of the formula (XXVII) WO 97-06171</li><li>(27) compound of the formula (XXVIII) DE-A1-196 46 407, EP-B-0 712 396</li><li>(28) compound of the formula (XXIX) US 3,290,353</li><li>(29) compound of the formula (XXX) DE-A-156 7169</li><li>(30) compound of formula (XXXI) EP-A-0 031 257</li><li>(31) compound of formula (XXXII) EP-A-0 639 547</li><li>(32) compound of formula (XXXIII) EP-A-0 298 196</li><li>(33) compound of the formula (XXXIV) EP-A-600 629</li><li>(34) compound of the formula (XXXV) DE-A-2 149 923</li><li>(35) compound of the formula (XXXVI) DE-A-2 012 656</li><li>(36) compound of formula (XXXVII) US 1 972 961</li><li>(37) compound of the formula (XXXVIII) EP-A-326 330</li><li>(38) compound of the formula (XXXIX) EP-A 278 595</li><li>(39) compound of the formula (XXXX) DE-A-3 030 026</li><li>(40) compound of the formula (XXXXI) DE-A-2 903 612</li><li>(41) compound of formula (XXXXII) U.S. 2,553,770</li><li>(42) compound of the formula (XXXXIII) known and available for purchase</li><li>(43) compound of the formula (XXXXIV) EP-A-206 999</li><li>(44) compound of formula (XXXXV) EP-A-78 663</li><li>(45) <ul id="ul0006" list-style="none" compact="compact"><li>a) compound of the formula (XXXXVIa) known and available for purchase</li><li>b) compound of the formula (XXXXVIb) known and available for purchase</li></ul></li><li>(46) compound of the formula (XXXXVII) DE-A-2 429 523</li><li>(47) <ul id="ul0007" list-style="none"><li>a) Compound of the formula (XXXXVIIIa) EP-A-112 284</li><li>b) compound of the formula (XXXXVIIIb) DE-A-3 042 303</li><li>c) compound of the formula (XXXXVIIIc) DE-A-3 406 993</li><li>d) compound of the formula (XXXXVIIId) EP-A-68 813</li><li>e) compound of the formula (XXXXVIIIe) DE-A-2551560</li><li>f) Compound of the formula (XXXXVIIIf) EP-A-145 294</li><li>g) Compound of the formula (XXXXVIIIg) DE-A-3 721 786</li><li>h) compound of the formula (XXXXVIIIh) EP-A-234 242</li></ul></li><li>(48) compound of the formula (XXXXIX) WO 96/23763</li><li>(49) compound of the formula (XXXXX) EP-A-596 254</li><li>(50) compound of the formula (XXXXXI) WO 98/23155</li><li>(51) compound of the formula (XXXXXII) EP-A-569 384.</li></ul>
In addition to an active ingredient of the formula (I), the active compound combinations according to the invention contain at least one active ingredient from the compounds of groups (1) to (51). They can also contain other fungicidally active admixing components.
If the active ingredients are present in the active ingredient combinations according to the invention in certain weight ratios, the synergistic effect is particularly evident. However, the weight ratios of the active ingredients in the active ingredient combinations can be varied within a relatively wide range. In general, 1 part by weight of active compound of the formula (I)<ul id="ul0008" list-style="none"><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (1),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (2),</li><li>1 up to 150 parts by weight, preferably 1 to 100 parts by weight, of active ingredient from group (3),</li><li>0.1 to 10 parts by weight, preferably 0.2 to 5 parts by weight of active ingredient from group (4),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight of active ingredient from group (5),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from group (6),</li><li>0.1 to 50 parts by weight, preferably 1 to 20 parts by weight, of active ingredient from group (7),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (8),</li><li>0.02 to 50 parts by weight, preferably 0.1 to 10 parts by weight of active ingredient from group (9),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (10),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (11),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (12).</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (13),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (14),</li><li>0.2 to 50 parts by weight, preferably 1 to 20 parts by weight, of active ingredient from group (15),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (16),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (17),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight of active ingredient from the group (18),</li><li>0.1 to 150 parts by weight, preferably 1 to 100 parts by weight, of active ingredient from group (19),</li><li>0.02 to 50 parts by weight, preferably 0.2 to 10 parts by weight, of active ingredient from group (20),</li><li>0.05 to 20 parts by weight, preferably 0.1 to 10 parts by weight of active ingredient from group (21),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (22),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (23),</li><li>0.01 to 150 parts by weight, preferably 1 to 100 parts by weight, of active ingredient from group (24),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (25),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (26),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (27),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from group (28),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from group (29),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (30),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (31),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (32),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (33),</li><li>0.1 to 50 parts by weight, preferably 1 to 20 parts by weight of active ingredient from the group (34),</li><li>0.1 to 50 parts by weight, preferably 1 to 10 parts by weight, of active ingredient from group (35),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from group (36),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (37).</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (38),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (39),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (40),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from group (41),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from group (42),</li><li>0.1 to 50 parts by weight, preferably 1 to 20 parts by weight, of active ingredient from group (43),</li><li>0.1 to 50 parts by weight, preferably 1 to 20 parts by weight of active ingredient from the group (44),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from the group (45a),</li><li>1 up to 150 parts by weight, preferably 5 to 100 parts by weight, of active ingredient from the group (45b),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (46),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (47a),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from group (47b),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (47c),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (47d),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight, of active ingredient from the group (47e),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (47f),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (47 g),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (47 h),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (48),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from the group (49),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (50),</li><li>0.1 to 50 parts by weight, preferably 0.2 to 20 parts by weight of active ingredient from group (51).</li></ul>
The active compound combinations according to the invention have very good fungicidal properties and can be used to control phytopathogenic fungi, such as Plasmodiophoromycetes, Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes, Deuteromycetes, etc.
The active compound combinations according to the invention are particularly suitable for combating Phytophthora infestans and Plasmopara viticola.
The fact that the active ingredient combinations are well tolerated by plants in the concentrations required to combat plant diseases allows treatment of above-ground parts of plants, of propagation stock and seeds, and of the soil. The active compound combinations according to the invention can be used for leaf application or as a mordant.
The active compound combinations according to the invention are also suitable for increasing the crop yield. They are also less toxic and have good plant tolerance.
According to the invention, all plants and parts of plants can be treated. Plants are understood here to mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Cultivated plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant cultivars which can or cannot be protected by plant breeders' rights. Plant parts are to be understood to mean all above-ground and underground parts and organs of plants, such as shoots, leaves, flowers and roots, examples being leaves, needles, stems, stems, flowers, fruiting bodies, fruits and seeds as well as roots, tubers and rhizomes. The plant parts also include crops and vegetative and generative propagation material, for example cuttings, tubers, rhizomes, offshoots and seeds.
The treatment of the plants and parts of plants with the active compounds according to the invention is carried out directly or by acting on their surroundings, living space or storage space according to the customary treatment methods, for example by dipping, spraying, evaporating, atomizing, scattering, spreading and in the case of propagation material, in particular seeds single or multi-layer wrapping.
The active compound combinations according to the invention can be converted into the customary formulations, such as solutions, emulsions, suspensions, powders, foams, pastes, granules, aerosols, very fine encapsulations in polymeric substances and in coating compositions for seeds, and ULV formulations.
These formulations are prepared in a known manner, for example by mixing the active ingredients or combinations of active ingredients with extenders, that is to say liquid solvents, pressurized liquefied gases and / or solid carriers, optionally using surface-active agents, that is to say emulsifiers and / or dispersants and / or foam-generating agents. In the case of the use of water as an extender, for example organic solvents can also be used as auxiliary solvents. The following are essentially suitable as liquid solvents: aromatics, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chlorethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example Petroleum fractions, alcohols, such as butanol or glycol, and their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide and dimethyl sulfoxide, and water. Liquefied gaseous extenders or carriers mean liquids which are gaseous at normal temperature and under normal pressure, for example aerosol propellants such as butane, propane, nitrogen and carbon dioxide. The following are suitable as solid carriers: for example natural rock powders such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth and synthetic rock powders such as highly disperse silica, aluminum oxide and silicates. Possible solid carriers for granules are: eg broken and fractionated natural rocks such as calcite, marble, pumice, sepiolite, dolomite as well as synthetic granules from inorganic and organic flours as well as granules from organic material such as sawdust, coconut shells, corn cobs and tobacco stems. Suitable emulsifying and / or foam-generating agents are: for example nonionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example Alkylaryl polyglycol ethers, alkyl sulfonates, alkyl sulfates, aryl sulfonates and protein hydrolyzates. Possible dispersing agents are, for example, lignin sulfite waste liquor and methyl cellulose.
Adhesives such as carboxymethyl cellulose, natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol, polyvinyl acetate, and also natural phospholipids, such as cephalins and lecithins, and synthetic phospholipids can be used in the formulations. Other additives can be mineral and vegetable oils.
Dyes such as inorganic pigments, for example iron oxide, titanium oxide, ferrocyan blue and organic dyes, such as alizarin, azo and metal phthalocyanine dyes and trace nutrients, such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc, can be used.
The formulations generally contain between 0.1 and 95% by weight of active ingredients, preferably between 0.5 and 90%.
The active compound combinations according to the invention, as such or in their formulations, can also be used in a mixture with known fungicides, bactericides, acaricides, nematicides or insecticides, in order, for example, to broaden the spectrum of action or to prevent the development of resistance. In many cases, synergistic effects are obtained, ie the effectiveness of the mixture is greater than the effectiveness of the individual components.
A mixture with other known active ingredients, such as herbicides or with fertilizers and growth regulators, is also possible.
The active substance combinations can be used as such, in the form of their formulations or the use forms prepared therefrom, such as ready-to-use solutions, emulsifiable concentrates, emulsions, suspensions, wettable powders, soluble powders and granules. They are used in the customary manner, for example by pouring, spraying, atomizing, scattering, spreading, dry pickling, wet pickling, wet pickling, slurry pickling or incrusting.
When using the active compound combinations according to the invention, the application rates can be varied within a substantial range, depending on the type of application. In the treatment of parts of plants, the application rates of active compound combination are generally between 0.1 and 10,000 g / ha, preferably between 10 and 1,000 g / ha. In the case of seed treatment, the application rates of the active compound combination are generally between 0.001 and 50 g per kg of seed, preferably between 0.01 and 10 g per kg of seed. In the treatment of the soil, the active compound combination application rates are generally between 0.1 and 10,000 g / ha, preferably between 1 and 5,000 g / ha.
The good fungicidal activity of the active compound combinations according to the invention can be seen from the examples below. While the individual active ingredients have weaknesses in their fungicidal action, the combinations show an action that goes beyond a simple summation of action.
Fungicides always have a synergistic effect if the fungicidal activity of the active ingredient combinations is greater than the sum of the effects of the individually applied active ingredients.
The expected effect for a given combination of two active ingredients can be according to SR Colby ("Calculating Synergistic and Antagonistic Responses of Herbicide Combinations", Weeds <u>15</u> (1967), 20-22) can be calculated as follows: If<dl id="dl0006"><dt>X</dt><dd>the efficiency when using the active ingredient A in an application rate of <u>m</u> g / ha means</dd><dt>Y</dt><dd>the efficiency when using the active ingredient B in an application rate of <u>n</u> g / ha means and</dd><dt>E</dt><dd>the efficiency when using the active ingredients A and B in application rates of <u>m</u> and <u>n</u> g / ha means</dd></dl> then<maths id="math0001" num=""><math display="block"><mrow><mtext>E = X + Y - </mtext><mfrac><mrow><mtext>XY </mtext></mrow><mrow><mtext>100</mtext></mrow></mfrac></mrow></math><img file="EP1239733B1_D0078.tif" /></maths>
The efficiency is determined in%. It means 0% an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
If the actual fungicidal activity is greater than calculated, the combination of the combination is superadditive, ie there is a synergistic effect. In this case, the actually observed efficiency must be greater than the value for the expected efficiency (E) calculated from the above formula.
The invention is illustrated by the following examples. However, the invention is not limited to the examples.
<u>example 1</u>
Phytophthora test (tomato) / protective
<tables id="tabl0001" num="0001"><table frame="all"><tgroup cols="2" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="78.75mm" /><colspec colnum="2" colname="col2" colwidth="78.75mm" /><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">solvent</entry><entry namest="col2" nameend="col2" align="left">47 Parts by weight of acetone</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Emulsifier</entry><entry namest="col2" nameend="col2" align="left">3rd Parts by weight of alkylaryl polyglycol ether</entry></row></tbody></tgroup></table></tables>
To produce a suitable preparation of active compound, 1 part by weight of active compound or combination of active compounds is mixed with the stated amounts of solvent and emulsifier and the concentrate is diluted with water to the desired concentration or a commercially available formulation of active compound or combination of active compounds with water is diluted to the desired concentration.
To test for protective activity, young plants are sprayed with the active compound preparation in the stated application rate. After the spray coating has dried on, the plants are inoculated with an aqueous spore suspension of Phytophthora infestans. The plants are then placed in an incubation cabin at approx. 20 ° C and 100% relative humidity.
3rd Evaluation is carried out days after the inoculation. 0% means an efficiency that corresponds to that of the control, while an efficiency of 100% means that no infection is observed.
The activity found of the active compound combination according to the invention is greater than the calculated activity, ie there is a synergistic effect. The combination of the compound of the formula (I) and the halogenobenzimidazole of the formula No. XXVII has an actual efficiency of 73% at a mixing ratio of 1: 1 and an application rate of 0.1 g / ha. The expected value calculated using the Colby formula is significantly lower at 63%.
Active substances, application rates and test results are shown in the following tables.<tables id="tabl0002" num="0002"><img file="EP1239733B1_D0079.tif" /></tables><tables id="tabl0003" num="0003"><img file="EP1239733B1_D0080.tif" /></tables><tables id="tabl0004" num="0004"><img file="EP1239733B1_D0081.tif" /></tables><tables id="tabl0005" num="0005"><img file="EP1239733B1_D0082.tif" /></tables><tables id="tabl0006" num="0006"><img file="EP1239733B1_D0083.tif" /></tables><tables id="tabl0007" num="0007"><img file="EP1239733B1_D0084.tif" /></tables><tables id="tabl0008" num="0008"><img file="EP1239733B1_D0085.tif" /></tables><tables id="tabl0009" num="0009"><img file="EP1239733B1_D0086.tif" /></tables><tables id="tabl0010" num="0010"><img file="EP1239733B1_D0087.tif" /></tables><tables id="tabl0011" num="0011"><img file="EP1239733B1_D0088.tif" /></tables><tables id="tabl0012" num="0012"><img file="EP1239733B1_D0089.tif" /></tables><tables id="tabl0013" num="0013"><img file="EP1239733B1_D0090.tif" /></tables><tables id="tabl0014" num="0014"><img file="EP1239733B1_D0091.tif" /></tables><tables id="tabl0015" num="0015"><img file="EP1239733B1_D0092.tif" /></tables><tables id="tabl0016" num="0016"><img file="EP1239733B1_D0093.tif" /></tables><tables id="tabl0017" num="0017"><img file="EP1239733B1_D0094.tif" /></tables><tables id="tabl0018" num="0018"><img file="EP1239733B1_D0095.tif" /></tables><tables id="tabl0019" num="0019"><img file="EP1239733B1_D0096.tif" /></tables><tables id="tabl0020" num="0020"><img file="EP1239733B1_D0097.tif" /></tables><tables id="tabl0021" num="0021"><img file="EP1239733B1_D0098.tif" /></tables><tables id="tabl0022" num="0022"><img file="EP1239733B1_D0099.tif" /></tables><tables id="tabl0023" num="0023"><img file="EP1239733B1_D0100.tif" /></tables><tables id="tabl0024" num="0024"><img file="EP1239733B1_D0101.tif" /></tables><tables id="tabl0025" num="0025"><img file="EP1239733B1_D0102.tif" /></tables><tables id="tabl0026" num="0026"><img file="EP1239733B1_D0103.tif" /></tables><tables id="tabl0027" num="0027"><img file="EP1239733B1_D0104.tif" /></tables><tables id="tabl0028" num="0028"><img file="EP1239733B1_D0105.tif" /></tables><tables id="tabl0029" num="0029"><img file="EP1239733B1_D0106.tif" /></tables><tables id="tabl0030" num="0030"><img file="EP1239733B1_D0107.tif" /></tables><tables id="tabl0031" num="0031"><img file="EP1239733B1_D0108.tif" /></tables><tables id="tabl0032" num="0032"><img file="EP1239733B1_D0109.tif" /></tables><tables id="tabl0033" num="0033"><img file="EP1239733B1_D0110.tif" /></tables><tables id="tabl0034" num="0034"><img file="EP1239733B1_D0111.tif" /></tables><tables id="tabl0035" num="0035"><img file="EP1239733B1_D0112.tif" /></tables><tables id="tabl0036" num="0036"><img file="EP1239733B1_D0113.tif" /></tables><tables id="tabl0037" num="0037"><img file="EP1239733B1_D0114.tif" /></tables><tables id="tabl0038" num="0038"><img file="EP1239733B1_D0115.tif" /></tables><tables id="tabl0039" num="0039"><img file="EP1239733B1_D0116.tif" /></tables><tables id="tabl0040" num="0040"><img file="EP1239733B1_D0117.tif" /></tables><tables id="tabl0041" num="0041"><img file="EP1239733B1_D0118.tif" /></tables><tables id="tabl0042" num="0042"><img file="EP1239733B1_D0119.tif" /></tables><tables id="tabl0043" num="0043"><img file="EP1239733B1_D0120.tif" /></tables>
345 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59 Sheet 60 Sheet 61 Sheet 62 Sheet 63 Sheet 64 Sheet 65 Sheet 66 Sheet 67 Sheet 68 Sheet 69 Sheet 70 Sheet 71 Sheet 72 Sheet 73 Sheet 74 Sheet 75 Sheet 76 Sheet 77 Sheet 78 Sheet 79 Sheet 80 Sheet 81 Sheet 82 Sheet 83 Sheet 84 Sheet 85 Sheet 86 Sheet 87 Sheet 88 Sheet 89 Sheet 90 Sheet 91 Sheet 92 Sheet 93 Sheet 94 Sheet 95 Sheet 96 Sheet 97 Sheet 98 Sheet 99 Sheet 100 Sheet 101 Sheet 102 Sheet 103 Sheet 104 Sheet 105 Sheet 106 Sheet 107 Sheet 108 Sheet 109 Sheet 110 Sheet 111 Sheet 112 Sheet 113 Sheet 114 Sheet 115 Sheet 116 Sheet 117 Sheet 118 Sheet 119 Sheet 120 Sheet 121 Sheet 122 Sheet 123 Sheet 124 Sheet 125 Sheet 126 Sheet 127 Sheet 128 Sheet 129 Sheet 130 Sheet 131 Sheet 132 Sheet 133 Sheet 134 Sheet 135 Sheet 136 Sheet 137 Sheet 138 Sheet 139 Sheet 140 Sheet 141 Sheet 142 Sheet 143 Sheet 144 Sheet 145 Sheet 146 Sheet 147 Sheet 148 Sheet 149 Sheet 150 Sheet 151 Sheet 152 Sheet 153 Sheet 154 Sheet 155 Sheet 156 Sheet 157 Sheet 158 Sheet 159 Sheet 160 Sheet 161 Sheet 162 Sheet 163 Sheet 164 Sheet 165 Sheet 166 Sheet 167 Sheet 168 Sheet 169 Sheet 170 Sheet 171 Sheet 172 Sheet 173 Sheet 174 Sheet 175 Sheet 176 Sheet 177 Sheet 178 Sheet 179 Sheet 180 Sheet 181 Sheet 182 Sheet 183 Sheet 184 Sheet 185 Sheet 186 Sheet 187 Sheet 188 Sheet 189 Sheet 190 Sheet 191 Sheet 192 Sheet 193 Sheet 194 Sheet 195 Sheet 196 Sheet 197 Sheet 198 Sheet 199 Sheet 200 Sheet 201 Sheet 202 Sheet 203 Sheet 204 Sheet 205 Sheet 206 Sheet 207 Sheet 208 Sheet 209 Sheet 210 Sheet 211 Sheet 212 Sheet 213 Sheet 214 Sheet 215 Sheet 216 Sheet 217 Sheet 218 Sheet 219 Sheet 220 Sheet 221 Sheet 222 Sheet 223 Sheet 224 Sheet 225 Sheet 226 Sheet 227 Sheet 228 Sheet 229 Sheet 230 Sheet 231 Sheet 232 Sheet 233 Sheet 234 Sheet 235 Sheet 236 Sheet 237 Sheet 238 Sheet 239 Sheet 240 Sheet 241 Sheet 242 Sheet 243 Sheet 244 Sheet 245 Sheet 246 Sheet 247 Sheet 248 Sheet 249 Sheet 250 Sheet 251 Sheet 252 Sheet 253 Sheet 254 Sheet 255 Sheet 256 Sheet 257 Sheet 258 Sheet 259 Sheet 260 Sheet 261 Sheet 262 Sheet 263 Sheet 264 Sheet 265 Sheet 266 Sheet 267 Sheet 268 Sheet 269 Sheet 270 Sheet 271 Sheet 272 Sheet 273 Sheet 274 Sheet 275 Sheet 276 Sheet 277 Sheet 278 Sheet 279 Sheet 280 Sheet 281 Sheet 282 Sheet 283 Sheet 284 Sheet 285 Sheet 286 Sheet 287 Sheet 288 Sheet 289 Sheet 290 Sheet 291 Sheet 292 Sheet 293 Sheet 294 Sheet 295 Sheet 296 Sheet 297 Sheet 298 Sheet 299 Sheet 300 Sheet 301 Sheet 302 Sheet 303 Sheet 304 Sheet 305 Sheet 306 Sheet 307 Sheet 308 Sheet 309 Sheet 310 Sheet 311 Sheet 312 Sheet 313 Sheet 314 Sheet 315 Sheet 316 Sheet 317 Sheet 318 Sheet 319 Sheet 320 Sheet 321 Sheet 322 Sheet 323 Sheet 324 Sheet 325 Sheet 326 Sheet 327 Sheet 328 Sheet 329 Sheet 330 Sheet 331 Sheet 332 Sheet 333 Sheet 334 Sheet 335 Sheet 336 Sheet 337 Sheet 338 Sheet 339 Sheet 340 Sheet 341 Sheet 342 Sheet 343 Sheet 344 Sheet 345
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP1728428A3 | Cited by | European Patent Office (EPO) | Search report |
| EP1728428A2 | Cited by | European Patent Office (EPO) | Search report |
| EP0610764A | Cites | European Patent Office (EPO) | – |
| EP0775696A | Cites | European Patent Office (EPO) | – |
47 members in 26 offices
Priority claims14
| Document | Office | Kind | Date |
|---|---|---|---|
| 19959947 | Germany | A | |
| 19959947 | Germany | A | |
| 19959947 | Germany | – | |
| 10021412 | Germany | A | |
| 10021412 | Germany | A | |
| 10021412 | Germany | – | |
| 0011989 | European Patent Office (EPO) | W | |
| 0011989 | European Patent Office (EPO) | W | |
| 10021412 | – | – | – |
| 19959947 | – | – | – |
| DE1999159947 | – | – | – |
| DE2000121412 | – | – | – |
| EP0011989 | – | – | – |
| WO2000EP11989 | – | – | – |
Members47
| Document | Office | Kind | |
|---|---|---|---|
| CA2393988A1 | Canada | A1 | |
| DE10021412A1 | Germany | A1 | |
| WO0144215A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2164101A | Australia | A | |
| WO0144215A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20020059759A | Republic of Korea | A | |
| BR0016336A | Brazil | A | |
| EP1239733A2 | European Patent Office (EPO) | A2 | |
| CZ20022079A3 | Czechia | A3 | |
| IL149554D0 | Israel | D0 | |
| TR200201544T2 | Türkiye | T2 | |
| CO5221089A1 | Colombia | A1 | |
| MXPA02005835A | Mexico | A | |
| HU0203563A2 | Hungary | A2 | |
| HUP0203563A2 | Hungary | A2 | |
| AR026938A1 | Argentina | A1 | |
| HU0203563A3 | Hungary | A3 | |
| HUP0203563A3 | Hungary | A3 | |
| CN1409596A | China | A | |
| ZA200203650B | South Africa | B | |
| JP2003516979A | Japan | A | |
| US2003105146A1 | United States of America | A1 | |
| EP1239733B1This record | European Patent Office (EPO) | B1 | |
| AT243933T | Austria | T | |
| ATE243933T1 | Austria | T1 | |
| DE50002776D1 | Germany | D1 | |
| US6624183B2 | United States of America | B2 | |
| DK1239733T3 | Denmark | T3 | |
| NZ519460A | New Zealand | A | |
| PT1239733E | Portugal | E | |
| ES2197124T3 | Spain | T3 | |
| RU2002119003A | Russian Federation | A | |
| US2004029840A1 | United States of America | A1 | |
| PL355756A1 | Poland | A1 | |
| TW590741B | Taiwan Province of China | B | |
| CN1547911A | China | A | |
| CN1212768C | China | C | |
| US2006172981A1 | United States of America | A1 | |
| KR100613238B1 | Republic of Korea | B1 | |
| US7115593B2 | United States of America | B2 | |
| US7208510B2 | United States of America | B2 | |
| US2007161688A1 | United States of America | A1 | |
| IL149554A | Israel | A | |
| PL200668B1 | Poland | B1 | |
| CZ301233B6 | Czechia | B6 | |
| CN101627772A | China | A | |
| US7956009B2 | United States of America | B2 |
67 legal events, as 11 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapse due to non-payment of feesLapsedML | ML | GR | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed because of non-payment of the annual feeLapsedV1 | V1 | NL | |
| Annulment/lapse due to non-payment of fees, searched and examined patentLapsedLAPSE DUE TO NON-PAYMENT OF FEESMM4A | MM4A | PT | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Name/firm changedPFA | PFA | CH | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Lt: invalidation of european patent or patent extensionLTIE | LTIE | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Ep patent validated in greeceEP | EP | GR | |
| Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT | GBT | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedGERMANFG4D | FG4D | IE | |
| New agentNV | NV | CH | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedNOT ENGLISHFG4D | FG4D | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAL;LT;LV;MK;RO;SIAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1239733
- Publication, DOCDB
- 1239733
- Publication, EPODOC
- EP1239733
- Application
- 985119
- Application, DOCDB
- 00985119
- Application, EPODOC
- EP20000985119
Titles3
- German
- FUNGIZIDE WIRKSTOFFKOMBINATIONEN
- English
- FUNGICIDAL COMBINATIONS OF ACTIVE SUBSTANCES
- French
- COMBINAISONS FONGICIDES DE SUBSTANCES ACTIVES
Classification
- CPC, 1
- A01N47/12
- IPC, 30
- A01N37 18
- A01N37 22
- A01N37 24
- A01N37 34
- A01N37 50
- A01N41 06
- A01N43 28
- A01N43 36
- A01N43 38
- A01N43 40
- A01N43 42
- A01N43 50
- A01N43 54
- A01N43 653
- A01N43 76
- A01N43 78
- A01N43 80
- A01N43 828
- A01N43 84
- A01N43 88
- A01N47 12
- A01N47 14
- A01N47 20
- A01N47 34
- A01N47 44
- A01N51 00
- A01N53 12
- A01N55 00
- A01N57 12
- A01N59 26
Designated states20
- Contracting states, 20
- Austria
- Belgium
- Switzerland
- Cyprus
- Germany
- Denmark
- Spain
- Finland
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden
- Türkiye
